{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:02:50Z","timestamp":1776405770279,"version":"3.51.2"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100017577","name":"Public Welfare Project of Zhejiang Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["LGF18H160003"],"award-info":[{"award-number":["LGF18H160003"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2014KYB219"],"award-info":[{"award-number":["2014KYB219"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2017196976"],"award-info":[{"award-number":["2017196976"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004862","name":"Key Project of Zhejiang Province Science and Technology Plan","doi-asserted-by":"publisher","award":["2014C03048-1"],"award-info":[{"award-number":["2014C03048-1"]}],"id":[{"id":"10.13039\/501100004862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472861"],"award-info":[{"award-number":["81472861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014768","name":"Jiaxing science and technology project","doi-asserted-by":"publisher","award":["2018AD32036"],"award-info":[{"award-number":["2018AD32036"]}],"id":[{"id":"10.13039\/501100014768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title> Background:<\/jats:title>\n<jats:p>Multiple endocrine neoplasia type 2B (MEN 2B) is mainly caused by\nM918T RET germline mutation, and characterized by medullary thyroid carcinoma (MTC),\npheochromocytoma (PHEO) and non-endocrine features. However, the diagnosis and treatment are\nusually delayed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study reports 5 Chinese pedigrees with 5 individuals harboring germline RETM918T,\nand systematically reviewed previous Chinese literature reported.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>All 5 patients initially presented MTC, but none had biochemically cured postoperatively.\n2 also presented bilateral PHEO after adrenal-sparing surgery, 1 needed steroid replacement. Further,\na total of 32 MEN 2B patients from literature were clustered with 28 available for analysis. 26\n(92.8%) were diagnosed by endocrine-related symptoms; the remaining 2 (7.2%) due to RET testing\nand oral symptoms, respectively. 25 patients underwent thyroidectomy with\/without neck\nlymph node dissection at the mean age of (23.3 \u00b1 10.4) years. Histopathological examination revealed\nMTC (100%). Of them, 17 had definite TNM stage, with 1 in stage III and others in IV.\nOther information of MEN 2B-related symptoms included penetrance of PHEO (60.7%), constipation\n(32.1%), Hirschsprung disease (25%), alacrima (17.8%), mucosal ganglioneuroma (96.4%)\nand marfanoid habitus (71.4%). 19 patients were verified harboring RET-M918T (c.2753T&gt;C), of\nwhom 15 (78.9%) were de novo mutation. The other 9 were clinically diagnosed as MEN 2B.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion &amp; Conclusion :<\/jats:title>\n<jats:p>The initial diagnosis of MEN 2B is relatively later, and diagnosed by\nnon-endocrine components is extremely lower. Recognition of MEN 2B and its non-endocrine-related\ncomponents is still the utmost requirement for a Chinese physician. Combined RET screening\nand serum calcitonin detection can facilitate early diagnosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320666200910112230","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:52:36Z","timestamp":1599825156000},"page":"534-543","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-8989","authenticated-orcid":true,"given":"Zhe-Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-9554","authenticated-orcid":true,"given":"Xiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Second Hospital of Jiaxing, Jiaxing, Zhejiang Province,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-0727","authenticated-orcid":true,"given":"Xiao-Ping","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Oncologic and Urologic Surgery, the 903rd PLA Hospital, Wenzhou Medical University, Hangzhou, Zhejiang Province,China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"Mulligan L.M.","year":"1993","unstructured":"Mulligan L.M.; Kwok J.B.; Healey C.S.; Elsdon M.J.; Eng C.; Gardner E.; Love D.R.; Mole S.E.; Moore J.K.; Papi L.; Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993,363(6428),458-460","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s00259-016-3404-7","volume":"43","author":"Treglia G.","year":"2016","unstructured":"Treglia G.; Aktolun C.; Chiti A.; Frangos S.; Giovanella L.; Hoffmann M.; Iakovou I.; Mihailovic J.; Krause B.J.; Langsteger W.; Verburg F.A.; Luster M.; The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the \u201cevidence-based\u201d refusal to endorse them by EANM due to the \u201cnot evidence-based\u201d marginalization of the role of nuclear medicine. Eur J Nucl Med Mol Imaging EANM and the EANM Thyroid Committee2016,43(8),1486-1490","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"Wells S. A.","year":"2015","unstructured":"Wells S. A.; Asa S. L.; Dralle H.; Elisei R.; Evans D. B.; Gagel R. F.; Lee N.; Machens A.; Moley J. F.; Pacini F.; Raue F.; Frank-Raue K.; Robinson B.; Rosenthal M. S.; Santoro M.; Schlumberger M.; Shah M.; Waguespack S. G.; American Thyroid Association Guidelines Task Force on Medullary Thyroid C. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015,25(6),567-610","journal-title":"Thyroid"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","volume":"3","author":"Eng C.","year":"1994","unstructured":"Eng C.; Smith D.P.; Mulligan L.M.; Nagai M.A.; Healey C.S.; Ponder M.A.; Gardner E.; Scheumann G.F.; Jackson C.E.; Tunnacliffe A.; Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 1994,3(2),237-241","journal-title":"Hum Mol Genet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/ERC-17-0209","volume":"25","author":"Castinetti F.","year":"2018","unstructured":"Castinetti F.; Moley J.; Mulligan L.; Waguespack S.G.; A comprehensive review on MEN2B. Endocr Relat Cancer 2018,25(2),T29-T39","journal-title":"Endocr Relat Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"T69","DOI":"10.1530\/ERC-17-0335","volume":"25","author":"Grey J.","year":"2018","unstructured":"Grey J.; Winter K.; Patient quality of life and prognosis in multiple endocrine neoplasia type 2. Endocr Relat Cancer 2018,25(2),T69-T77","journal-title":"Endocr Relat Cancer"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/ERC-17-0325","volume":"25","author":"Wells S.A.","year":"2018","unstructured":"Wells S.A.; Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors. Endocr Relat Cancer 2018,25(2),T1-T13","journal-title":"Endocr Relat Cancer"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"Eng C.","year":"1996","unstructured":"Eng C.; Clayton D.; Schuffenecker I.; Lenoir G.; Cote G.; Gagel R.F.; van Amstel H.K.; Lips C.J.; Nishisho I.; Takai S.I.; Marsh D.J.; Robinson B.G.; Frank-Raue K.; Raue F.; Xue F.; Noll W.W.; Romei C.; Pacini F.; Fink M.; Niederle B.; Zedenius J.; Nordenskj\u00f6ld M.; Komminoth P.; Hendy G.N.; Mulligan L.M.; The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996,276(19),1575-1579","journal-title":"JAMA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/thy.2010.0328","volume":"21","author":"Jasim S.","year":"2011","unstructured":"Jasim S.; Ying A. K.; Waguespack S. G.; Rich T. A.; Grubbs E. G.; Jimenez C.; Hu M. I.; Cote G.; Habra M. A.; Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 2011,21(2),189-192","journal-title":"Thyroid"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1530\/EC-18-0220","volume":"7","author":"Qi X.P.","year":"2018","unstructured":"Qi X.P.; Peng J.Z.; Yang X.W.; Zao Z.L.; Yu X.H.; Fang X.D.; Zhang D.H.; Zhao J.Q.; The RET C611Y mutation causes MEN 2A and associated cutaneous. Endocr Connect 2018,7(9),998-1005","journal-title":"Endocr Connect"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"Edge S.B.","year":"2010","unstructured":"Edge S.B.; Compton C.C.; The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Annals of surgical oncology 2010,17,1471-1474","journal-title":"Annals of surgical oncology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","volume":"259","author":"Brauckhoff M.","year":"2014","unstructured":"Brauckhoff M.; Machens A.; Lorenz K.; Bj\u00f8ro T.; Varhaug J.E.; Dralle H.; Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective. Ann Surg 2014,259(4),800-806","journal-title":"Ann Surg"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07357907.2018.1430813","volume":"36","author":"Qi X.P.","year":"2018","unstructured":"Qi X.P.; Zhao J.Q.; Cao Z.L.; Fu E.; Li F.; Zhao Y.H.; Wang G.P.; Li P.F.; Ma W.L.; Guo J.; Jia H.; The clinical spectrum of multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis in Ethnic Han Chinese. Cancer Invest 2018,36(2),141-151","journal-title":"Cancer Invest"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4158\/EP171875.OR","volume":"23","author":"Gallagher T.M.","year":"2017","unstructured":"Gallagher T.M.; Bucciarelli M.; Kavalukas S.L.; Baker M.J.; Saunders B.D.; Attitudes toward genetic counseling and testing in patients with inherited endocrinopathies. Endocr Pract 2017,23(9),1039-1044","journal-title":"Endocr Pract"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4158\/EP12430.RA","volume":"19","author":"Griebeler M. L.","year":"2013","unstructured":"Griebeler M. L.; Gharib H.; Thompson G. B.; Medullary thyroid carcinoma Endocr Pract 2013,19(4),703-711","journal-title":"Endocr Pract"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1210\/jc.2018-00705","volume":"104","author":"Makri A.","year":"2019","unstructured":"Makri A.; Akshintala S.; Derse-Anthony C.; Del Rivero J.; Widemann B.; Stratakis C.A.; Glod J.; Lodish M.; Pheochromocytoma in children and adolescents with multiple endocrine neoplasia type 2B. J Clin Endocrinol Metab 2019,104(1),7-12","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","volume":"7","author":"Castinetti F.","year":"2019","unstructured":"Castinetti F.; Waguespack S.G.; Machens A.; Uchino S.; Hasse-Lazar K.; Sanso G.; Else T.; Dvorakova S.; Qi X.P.; Elisei R.; Maia A.L.; Glod J.; Louren\u00e7o D.M.; Valdes N.; Mathiesen J.; Wohllk N.; Bandgar T.R.; Drui D.; Korbonits M.; Druce M.R.; Brain C.; Kurzawinski T.; Patocs A.; Bugalho M.J.; Lacroix A.; Caron P.; Fainstein-Day P.; Borson Chazot F.; Klein M.; Links T.P.; Letizia C.; Fugazzola L.; Chabre O.; Canu L.; Cohen R.; Tabarin A.; Spehar Uroic A.; Maiter D.; Laboureau S.; Mian C.; Peczkowska M.; Sebag F.; Brue T.; Mirebeau-Prunier D.; Leclerc L.; Bausch B.; Berdelou A.; Sukurai A.; Vlcek P.; Krajewska J.; Barontini M.; Vaz Ferreira Vargas C.; Valerio L.; Ceolin L.; Akshintala S.; Hoff A.; Godballe C.; Jarzab B.; Jimenez C.; Eng C.; Imai T.; Schlumberger M.; Grubbs E.; Dralle H.; Neumann H.P.; Baudin E.; Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 2019,7(3),213-220","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/jc.2017-01884","volume":"103","author":"Raue F.","year":"2018","unstructured":"Raue F.; Dralle H.; Machens A.; Bruckner T.; Frank-Raue K.; Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium. J Clin Endocrinol Metab 2018,103(1),235-243","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fonc.2017.00238","volume":"7","author":"Priya S.R.","year":"2017","unstructured":"Priya S.R.; Dravid C.S.; Digumarti R.; Dandekar M.; Targeted therapy for medullary thyroid cancer: A review. Front Oncol 2017,7,238","journal-title":"Front Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"Castinetti F.","year":"2014","unstructured":"Castinetti F.; Qi X.P.; Walz M.K.; Maia A.L.; Sans\u00f3 G.; Peczkowska M.; Hasse-Lazar K.; Links T.P.; Dvorakova S.; Toledo R.A.; Mian C.; Bugalho M.J.; Wohllk N.; Kollyukh O.; Canu L.; Loli P.; Bergmann S.R.; Biarnes Costa J.; Makay O.; Patocs A.; Pfeifer M.; Shah N.S.; Cuny T.; Brauckhoff M.; Bausch B.; von Dobschuetz E.; Letizia C.; Barczynski M.; Alevizaki M.K.; Czetwertynska M.; Ugurlu M.U.; Valk G.; Plukker J.T.; Sartorato P.; Siqueira D.R.; Barontini M.; Szperl M.; Jarzab B.; Verbeek H.H.; Zelinka T.; Vlcek P.; Toledo S.P.; Coutinho F.L.; Mannelli M.; Recasens M.; Demarquet L.; Petramala L.; Yaremchuk S.; Zabolotnyi D.; Schiavi F.; Opocher G.; Racz K.; Januszewicz A.; Weryha G.; Henry J.F.; Brue T.; Conte-Devolx B.; Eng C.; Neumann H.P.; Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 2014,15(6),648-655","journal-title":"Lancet Oncol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"Lenders J.W.","year":"2014","unstructured":"Lenders J.W.; Duh Q.Y.; Eisenhofer G.; Gimenez-Roqueplo A.P.; Grebe S.K.; Murad M.H.; Naruse M.; Pacak K.; Young W.F.; Endocrine S.; Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Endocrine Society2014,99(6),1915-1942","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-17-0202","volume":"25","author":"Machens A.","year":"2018","unstructured":"Machens A.; Dralle H.; Advances in risk-oriented surgery for multiple endocrine neoplasia type 2. Endocr Relat Cancer 2018,25(2),T41-T52","journal-title":"Endocr Relat Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","volume":"98","author":"Thosani S.","year":"2013","unstructured":"Thosani S.; Ayala-Ramirez M.; Palmer L.; Hu M.I.; Rich T.; Gagel R.F.; Cote G.; Waguespack S.G.; Habra M.A.; Jimenez C.; The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 2013,98(11),E1813-E1819","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1515\/jpem.2011.262","volume":"24","author":"Altarescu G.","year":"2011","unstructured":"Altarescu G.; Barenholz O.; Renbaum P.; Beeri R.; Levy-Lahad E.; Margalioth E.J.; Brooks B.; Varshaver I.; Eldar-Geva T.; Preimplantation genetic diagnosis (PGD)--prevention of the birth of children affected with endocrine diseases. J Pediatr Endocrinol Metab 2011,24(7-8),543-548","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/thy.2016.0148","volume":"27","author":"Rodrigues K.C.","year":"2017","unstructured":"Rodrigues K.C.; Toledo R.A.; Coutinho F.L.; Nunes A.B.; Maciel R.M.B.; Hoff A.O.; Tavares M.C.; Toledo S.P.A.; Louren\u00e7o D.M.; Assessment of depression, anxiety, quality of life, and coping in long-standing multiple endocrine neoplasia type 2 patients. Thyroid 2017,27(5),693-706","journal-title":"Thyroid"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/185814","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/185814\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/185814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T14:53:22Z","timestamp":1641999202000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/185814\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200910112230","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}